Elekta AB (publ) (LON:0O5H)

Market Cap	1.42B
Revenue (ttm)	1.40B
Net Income (ttm)	18.36M
Shares Out	n/a
EPS (ttm)	0.05
PE Ratio	77.45
Forward PE	12.94
Dividend	0.18 (0.37%)
Ex-Dividend Date	Mar 6, 2025

Volume	59,829
Average Volume	500,986
Open	47.67
Previous Close	49.03
Day's Range	47.58 - 48.10
52-Week Range	44.50 - 76.30
Beta	1.09
RSI	43.84
Earnings Date	Jul 4, 2025

About Elekta AB

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as wel...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1972
• Employees: 4,556
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O5H

Financial Performance

In 2025, Elekta AB's revenue was 18.02 billion, a decrease of -0.57% compared to the previous year's 18.12 billion. Earnings were 237.00 million, a decrease of -81.80%.

Financial numbers in SEK